Deutsche Bank on Eli Lilly (LLY): 'CB-1 Appetite Suppression Looks Underwhelming'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
Eli Lilly (LLY) call put ratio 2.1 calls to 1 put as share price up 1.9%
September 20, 2024 11:03 AM EDTEli Lilly & Co. (NYSE: LLY) 30-day option implied volatility is at 27; compared to its 52-week range of 22 to 56. Call put ratio 2.1 calls to 1 put with focus on September 950 calls.
... MoreEli Lilly & Co. (LLY) gains after Novo Nordisk's monlunabant obesity data
September 20, 2024 9:23 AM EDTEli Lilly & Co. (NYSE: LLY) ticks higher following Novo Nordisk's update on Monlunabant phase 2a trial in obesity.
from Novo's release: "From a baseline body weight of 110.1 kg, all doses of monlunabant achieved a statistically significant weight loss compared to placebo. After 16... More
Eli Lilly & Co. (LLY) option IV near lower end of range
September 19, 2024 5:53 AM EDTEli Lilly & Co. (NYSE: LLY) 30-day option implied volatility is at 28; compared to its 52-week range of 22 to 55 on 100K contracts with a focus on September calls.
... More